Longeveron Receives Nasdaq Extension to Regain Minimum Bid Price Compliance

summarizeSummary

Longeveron Inc. received an additional 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement, pushing the deadline to September 21, 2026.

check_boxKey Events · Corporate Governance and Compliance · LGVN

• Nasdaq Grants Listing Extension

  Longeveron Inc. received an additional 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement, setting a new deadline of September 21, 2026.

• No Immediate Delisting

  The notice confirms that there is no immediate effect on the company's continued listing status on The Nasdaq Capital Market.

• Potential Reverse Stock Split

  The company stated its intention to monitor its stock price and assess options, including a reverse stock split, if necessary, to regain compliance.

• Ongoing Compliance Challenge

  This follows an initial delisting notice on September 22, 2025, highlighting the company's persistent challenge in meeting Nasdaq's minimum bid price rule amidst broader financial concerns.

auto_awesomeAnalysis · LGVN · Life Sciences

Longeveron Inc. has been granted an additional 180 days by Nasdaq, extending its compliance period for the $1.00 minimum bid price requirement until September 21, 2026. This extension provides a temporary reprieve from immediate delisting, which is critical for a company that recently disclosed substantial doubt about its ability to continue as a going concern in its 10-K filing on March 17, 2026. While the extension avoids an immediate negative outcome, the company still faces the challenge of raising its stock price, potentially through a reverse stock split, to maintain its Nasdaq listing. This situation underscores the ongoing financial pressures and the need for strategic actions to ensure long-term viability, following a highly dilutive private placement in mid-March.